서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2015-10	Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations Park, Sehhoon; Keam, Bhumsuk; Kim, Se Hyun; Kim, Ki Hwan; Kim, Yu Jung; Kim, Jin-Soo; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Lee, Jong Seok; Heo, Dae Seog Cancer Research and Treatment, Vol.47 No.4, pp.630-637	view file DOI
2015-12	MET amplification, protein expression, and mutations in pulmonary adenocarcinoma Park, Seongyeol; Koh, Jaemoon; Kim, Dong-Wan; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Chung, Doo Hyun; Heo, Dae Seog Lung Cancer, Vol.90 No.3, pp.381-387	DOI
2016-04	Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial Kang, Jin Hyoung; Ahn, Myung-Ju; Kim, Dong-Wan; Cho, Eun Kyung; Kim, Joo-Hang; Shin, Sang Won; Wang, Xin; Kim, Jong Seok; Orlando, Mauro; Park, Keunchil Cancer Research and Treatment, Vol.48 No.2, pp.458-464	view file DOI
2018-02	Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection Kim, Hyungjin; Chae, Kum Ju; Yoon, Soon Ho; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Goo, Jin Mo; Park, Chang Min European Radiology, Vol.28 No.2, pp.861-868	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2019-01	The risk of herpes zoster in patients with non-small cell lung cancer according to chemotherapy regimens: Tyrosine kinase inhibitors versus cytotoxic chemotherapy Choi, Ji Young; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Jo, Seong Jin Cancer Research and Treatment, Vol.51 No.1, pp.169-177	view file DOI
2020-01	Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies Ahn, Myung-Ju; Han, Ji-Youn; Kim, Dong-Wan; Cho, Byoung Chul; Kang, Jin-Hyoung; Kim, Sang-We; Yang, James Chih-Hsin; Mitsudomi, Tetsuya; Lee, Jong Seok Cancer Research and Treatment, Vol.52 No.1, pp.284-291	view file DOI
2023-01	Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis Cho, Byoung Chul; Kim, Dong-Wan; Batra, Ullas; Park, Keunchil; Kim, Sang-We; Yang, Cheng-Ta; Voon, Pei-Jye; Sriuranpong, Virote; Babu, K Govind; Amin, Khalid; Wang, Yingbo; Sen, Paramita; Slimane, Khemaies; Geater, Sarayut Cancer Research and Treatment, Vol.55 No.1, pp.83-93	DOI
2024-01	Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset Lee, Ki Hyeong; Cho, Byoung Chul; Ahn, Myung-Ju; Lee, Yun-Gyoo; Lee, Youngjoo; Lee, Jong-Seok; Kim, Joo-Hang; Min, Young Joo; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Kyung-Hee; Ko, Yoon Ho; Shim, Byoung Yong; Kim, Sang-We; Shin, Sang Won; Choi, Jin-Hyuk; Kim, Dong-Wan; Cho, Eun Kyung; Park, Keon Uk; Kim, Jin-Soo; Chun, Sang Hoon; Wang, Jangyoung; Choi, SeokYoung; Kang, Jin Hyoung Cancer research and treatment, Vol.56 No.1, pp.48-60	DOI

1